"10.1371_journal.pone.0110800","plos one","2014-10-24T00:00:00Z","Cheryl C Y Loh; Rossarin Suwanarusk; Yan Quan Lee; Kitti W K Chan; Kit-Ying Choy; Laurent Rénia; Bruce Russell; Martin J Lear; François H Nosten; Kevin S W Tan; Larry M C Chow","Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Singapore Immunology Network, Agency for Science Technology and Research, Biopolis, Singapore, Singapore; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore, Singapore; Department of Applied Biology and Chemical Technology, The State Key Laboratory of Chirosciences, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, PR China; Department of Chemistry, Graduate School of Science, Tohoku University, Aza Aramaki, Aoba-ku, Sendai, Japan; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand; Centre for Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom","Conceived and designed the experiments: KSWT BR FHN LR MJL LMCC. Performed the experiments: YQL CCYL KWKC KYC RS. Analyzed the data: YQL CCYL RS. Contributed reagents/materials/analysis tools: KSWT LR FHN. Wrote the paper: YQL KSWT BR FHN LR MJL LMCC CCYL KWKC KYC RS.","KSWT and MJL are founding directors of BioLynx Technologies (Singapore), a private company that specializes in fluorophore-conjugated drug surrogates including LynxTag-CQGREEN. Other authors declare no competing interests. KSWT and MJL own minority shares in BioLynx Technologies (Singapore). LR and BR are PLOS ONE Editorial Board Members. This does not alter the authors adherence to PLOS ONE Editorial policies and criteria.","2014","10","Cheryl C Y Loh","CCYL",11,FALSE,6,5,3,11,TRUE,TRUE,FALSE,0,NA,FALSE
